Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-04-28

Clinical Trial Update: Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing hypertonic saline 6% with isotonic saline 0.9% in bronchiectasis; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic saline 6% (Sodium chloride hypertonic solution 6%)
  • Isotonic saline 0.9% (Sodium chloride isotonic solution 0.9%)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Bronchiectasis | Phase 2 | Status: UNKNOWN